Chalcomoracin and moracin C, new inhibitors of Staphylococcus aureus enoyl-ACP reductase from Morus alba = 상엽에서 분리한 enoyl-ACP reductase 저해 황색포도상 구균 항세균 물질
Cited 29 time in
- Chalcomoracin and moracin C, new inhibitors of Staphylococcus aureus enoyl-ACP reductase from Morus alba = 상엽에서 분리한 enoyl-ACP reductase 저해 황색포도상 구균 항세균 물질
- Yu Jin Kim; M J Sohn; Won Gon Kim
- Bibliographic Citation
- Biological & Pharmaceutical Bulletin, vol. 35, no. 5, pp. 791-795
- Publication Year
- Bacterial enoyl-acyl carrier protein (ACP) reductase has been confirmed as a novel target for antibacterial drug development. In the screening of inhibitors of Staphylococcus aureus enoyl-ACP reductase (FabI), we found that a methanol extract of leaves of Morus alba L. potently inhibited S. aureus FabI as well as growth of S. aureus. The active principles were identified as chalcomoracin and moracin C by MS and NMR analysis. Chalcomoracin and moracin C inhibited S. aureus FabI with IC 50 of 5.5 and 83.8 μM, respectively. They also prevented the growth of S. aureus with minimum inhibitory concentration (MIC) of 4 and 32 μg/ mL, respectively. Consistent with their inhibition against FabI and bacterial growth, they prevented [ 14C]- acetate incorporation into fatty acid in S. aureus while didn't affect protein synthesis. In this study, we reported that chalcomoracin and moracin C, potent antibacterial compounds from Morus alba, inhibited FabI and fatty acid synthesis.
- Chalcomoracin; Enoyl-acyl carrier protein reductase; FabI; Fatty acid synthesis; Moracin C; Staphylococcus aureus
- Pharmaceutical Soc Japan
- Appears in Collections:
- Division of Research on National Challenges > Infectious Disease Research Center > 1. Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.